N-Methyl 7,8-didehydronaltrexone Bromide(1027638-96-5)
- Name: N-Methyl 7,8-didehydronaltrexone Bromide
- Synonyms:N-Methyl 7,8-didehydronaltrexone Bromide;
- Molecular Formula:C21H24BrNO4
- Molecular Weight:434.32356
- CAS Registry Number:1027638-96-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1027638-96-5 High quality N-Methyl 7,8-didehydronaltrexone Bromide with factory price
Assay:99% Appearance:detailed see specifications Package:according to customers' requirements Storage:Keep in a cool & dry place Transportation:By air(EMS or EUB or FedEx or TNT ect...) or by sea(FOB or CIF or CNF ect...)or according to your demand. Application:intermediates in organic synthesis
Min. Order:1Gram
Supplier:Hangzhou Lingrui Chemical Co.,Ltd. [
China (Mainland)] CAS No.1027638-96-5 N-Methyl 7,8-didehydronaltrexone Bromide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1027638-96-5 Methylnaltrexone Bromide Impurity 6
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 852212-89-6/N-[(1R,2R)-2-aMino-1,2-diphenylethyl]-1,1,1-trifluoro-MethanesulfonaMide
- 1034835-88-5/N-[(1R,2R)-2-[(11bS)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]-4-Methyl-BenzenesulfonaMide
- 1034835-89-6/N-[(1R,2R)-2-[(11bS)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]-1,2-diphenylethyl]-4-Methyl- BenzenesulfonaMide
- 1034835-90-9/N-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]-4-Methyl-BenzenesulfonaMide
- 1034835-91-0/N-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]-1,2-diphenylethyl]-4-Methyl- BenzenesulfonaMide
- 1211565-08-0/N-[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]-N′-[4-(trifluoroMethyl)phenyl]squaraMide
- 934762-68-2/2-PropanesulfinaMide, N-[(1R,2R)-2-[[[[3,5-bis(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]cyclohexyl]-2-Methyl-, [S(R)]-
- 54565-05-8/Propanebis(thioic) acid, S,S-bis(1-methylethyl) ester
- 250159-48-9/(SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-kN,kN']bis(tetradecanoato-kO)platinum monohydrate
- 774538-96-4/cis-Montelukast
- 35073-04-2/Pyridazinium, 1-amino-, iodide
- 743458-79-9/N,N'-(1R,2R)-1,2-cyclohexanediyl bis[N'-[3,5-bis(trifluoroMethyl)phenyl)] -Thiourea
- 199588-80-2/N-(9-ANTHRACENYLMETHYL)CINCHONINDINIUMCHLORIDE
- 1096162-93-4/Benzenesulfonamide, N-[(1S)-2,2-dimethyl-1-(1-pyrrolidinylmethyl)propyl]-4-methyl-
- 25221-53-8/(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)phosphoramidic dichloride
- 1027638-96-5/N-Methyl 7,8-didehydronaltrexone Bromide
- 24346-32-5/H-cys-tyr-ile-gln-asn-cys-pro-leu-gly-oh
- 913820-87-8/FMOC-(2R,4S)-PRO(4-F)-OH
- 913820-71-0/(4R)-4-Fluoro-D-proline
- 72204-23-0/(2S,Trans)-4-fluoro-1,2-pyrrolidinedicarboxylic acid 1-benzyl ester
- 30924-91-5/Boc-Glu-OBzlDCHA
- 2840-61-1/3-METHYL-5-OXO-5-PHENYLVALERIC ACID
- 201544-79-8/N-Me-DL-His-OH.2HCl
- 170983-98-9/β-4,5-dibenzoyl-2-cyano-D-deoxyribrate
- 1393441-75-2/Tert-butyl (((1r,4r)-4-aminocyclohexyl)methyl)carbamate hydrochloride
- 1241680-31-8/3,5-Dichloro-D-Phenylalanine
- 1217849-01-8/Boc-D-His(Boc)-OH.DCHA
- 1213639-41-8/BOC-D-4-CARBAMOYLPHE
- 1213190-47-6/BOC-D-3-CARBAMOYLPHE
- 60851-91-4/5-Heptyn-1-ol, 7-bromo-